According to the latest study from BCC Research, "Chronic Disease Management: Therapeutics, Device Technologies, and Global ...
Pfizer Inc. (NYSE:PFE) released topline results from its Phase 3 CREST trial evaluating sasanlimab, an investigational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback